Additionally, future studies should use pharmacological inhibitors of RIPK2 long-term following stroke to further investigate the therapeutic potential of RIPK2 inhibition to reduce inflammation and improve outcomes following ischemic stroke. This evidence concerns the gene RIPK2 and Stroke.